These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 22342850

  • 21. Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention.
    Kiviniemi T, Karjalainen P, Pietilä M, Ylitalo A, Niemelä M, Vikman S, Puurunen M, Biancari F, Airaksinen KE.
    Am J Cardiol; 2012 Jul 01; 110(1):30-5. PubMed ID: 22464216
    [Abstract] [Full Text] [Related]

  • 22. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z, Kala P.
    Clin Ther; 2008 Jul 01; 30 Pt 2():2191-202. PubMed ID: 19281914
    [Abstract] [Full Text] [Related]

  • 23. Antithrombotic treatment for patients on oral anticoagulation undergoing coronary stenting: a review of the available evidence and practical suggestions for the clinician.
    Rubboli A, Verheugt FW.
    Int J Cardiol; 2008 Jan 24; 123(3):234-9. PubMed ID: 17434621
    [Abstract] [Full Text] [Related]

  • 24. Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention.
    Rubboli A, Colletta M, Herzfeld J, Sangiorgio P, Di Pasquale G.
    Coron Artery Dis; 2007 May 24; 18(3):193-9. PubMed ID: 17429293
    [Abstract] [Full Text] [Related]

  • 25. Triple antithrombotic therapy versus double antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients requiring chronic oral anticoagulation: a meta-analysis.
    Saheb KJ, Deng BQ, Hu QS, Xie SL, Geng DF, Nie RQ.
    Chin Med J (Engl); 2013 Jul 24; 126(13):2536-42. PubMed ID: 23823830
    [Abstract] [Full Text] [Related]

  • 26. [How and when to use dual antiplatelet treatment in the patient treated with oral anticoagulants?].
    Rubboli A, Di Pasquale G.
    G Ital Cardiol (Rome); 2008 Nov 24; 9(11):745-52. PubMed ID: 19058665
    [Abstract] [Full Text] [Related]

  • 27. Optimal antithrombotic treatment in patients with an indication for long-term anticoagulation undergoing coronary artery stenting.
    Rubboli A, Di Pasquale G.
    Future Cardiol; 2006 Mar 24; 2(2):205-13. PubMed ID: 19804077
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents.
    Baber U, Akhter M, Kothari S, Sharma SK, Kini A.
    J Invasive Cardiol; 2010 Feb 24; 22(2):80-3. PubMed ID: 20124594
    [Abstract] [Full Text] [Related]

  • 29. Triple Antithrombotic Therapy after Percutaneous Coronary Intervention (PCI) in Patients with Indication for Oral Anticoagulation: Data from a Single Center Registry.
    Staudacher DL, Kaiser M, Hehrlein C, Bode C, Ahrens I.
    PLoS One; 2015 Feb 24; 10(10):e0140101. PubMed ID: 26439131
    [Abstract] [Full Text] [Related]

  • 30. Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
    Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, Sangiorgio P, Tarantino F, Geraci G, Castriota F, Tondi S, Saia F, Cooke RM, Guastaroba P, Grilli R, Marzocchi A, Maresta A.
    Circulation; 2008 Feb 19; 117(7):923-30. PubMed ID: 18250265
    [Abstract] [Full Text] [Related]

  • 31. Long-term clinical outcomes after drug eluting stent implantation in women with de novo coronary lesions. Results from the REAL (REgistro Regionale AngiopLastiche Emilia-Romagna) multicenter registry.
    Ortolani P, Solinas E, Guastaroba P, Casella G, Manari A, Piovaccari G, Balducelli M, Tondi S, Percoco G, Tarantino F, Passerini F, Rossi R, Vignali L, De Palma R, Grilli R, Marzocchi A.
    Int J Cardiol; 2011 May 19; 149(1):55-62. PubMed ID: 20060183
    [Abstract] [Full Text] [Related]

  • 32. Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]).
    Gilard M, Blanchard D, Helft G, Carrier D, Eltchaninoff H, Belle L, Finet G, Le Breton H, Boschat J, STENTICO Investigators.
    Am J Cardiol; 2009 Aug 01; 104(3):338-42. PubMed ID: 19616664
    [Abstract] [Full Text] [Related]

  • 33. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview.
    Rubboli A, Faxon DP, Juhani Airaksinen KE, Schlitt A, Marín F, Bhatt DL, Lip GY.
    Thromb Haemost; 2014 Dec 01; 112(6):1080-7. PubMed ID: 25298351
    [Abstract] [Full Text] [Related]

  • 34. Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry.
    Proietti M, Airaksinen KEJ, Rubboli A, Schlitt A, Kiviniemi T, Karjalainen PP, Lip GY, AFCAS Study Group.
    Am Heart J; 2017 Aug 01; 190():86-93. PubMed ID: 28760217
    [Abstract] [Full Text] [Related]

  • 35. Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST).
    Dewilde W, Berg JT.
    Am Heart J; 2009 Nov 01; 158(5):713-8. PubMed ID: 19853687
    [Abstract] [Full Text] [Related]

  • 36. Twelve-month outcome of patients with an established indication for oral anticoagulation undergoing coronary artery stenting and stratified by the baseline risk of bleeding: Insights from the Warfarin and Coronary Stenting (War-Stent) Registry.
    Rubboli A, Saia F, Sciahbasi A, Leone AM, Palmieri C, Bacchi-Reggiani ML, Calabrò P, Bordoni B, Piccalò G, Franco N, Nicolino A, Magnavacchi P, Vignali L, Mameli S, Dallago M, Maggiolini S, Steffanon L, Piovaccari G, Di Pasquale G, WARfarin and Coronary STENTing (WAR-STENT) Study group.
    Cardiovasc Revasc Med; 2017 Sep 01; 18(6):425-430. PubMed ID: 28363682
    [Abstract] [Full Text] [Related]

  • 37. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA.
    Am Heart J; 2000 Sep 01; 140(3):483-91. PubMed ID: 10966552
    [Abstract] [Full Text] [Related]

  • 38. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
    Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Valdés M, Lip GYH.
    Chest; 2008 Sep 01; 134(3):559-567. PubMed ID: 18641090
    [Abstract] [Full Text] [Related]

  • 39. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A.
    Circulation; 2007 Jun 26; 115(25):3181-8. PubMed ID: 17562952
    [Abstract] [Full Text] [Related]

  • 40. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C, Onuma Y, Magro M, de Boer S, Battes L, van Domburg RT, Boersma E, Serruys PW, Interventional Cardiologists of the Thoraxcenter (2000-2005).
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):41-9. PubMed ID: 20310019
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.